An Open-Label Follow-on Trial to Assess the Long-Term Safety and Efficacy of Oral SPM 927 in Subjects With Postherpetic Neuralgia (PHN).
Phase of Trial: Phase II
Latest Information Update: 31 Oct 2014
At a glance
- Drugs Lacosamide (Primary)
- Indications Postherpetic neuralgia
- Focus Therapeutic Use
- Sponsors UCB
- 19 Sep 2006 New trial record.